Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 271 - Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
Patents for C07D 271 - Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms (7,144)
10/2005
10/13/2005US20050227994 Decomposition inhibitor for extracellular matrix of cartilage
10/13/2005CA2562114A1 Sulfonamide compounds for the treatment of neurodegenerative disorders
10/13/2005CA2558446A1 Dpp-iv inhibitors
10/12/2005EP1583972A2 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
10/12/2005EP1583760A2 Substituted heterocyclic compounds
10/12/2005EP0794774B1 4,4-(disubstituted)cyclohexan-1-ols monomers and related compounds
10/11/2005US6953812 Carboxy and amide containing compound suitable for treatment and/or prevention of diseases wherein a glucagon antagonistic action is beneficial, such as hyperglycemia, diabetes, disorders of the lipid metabolism, such as dyslipidemia
10/06/2005WO2005092899A1 Inhibitors of histone deacetylase
10/06/2005WO2005092847A1 Dendron and dendrimer, method of producing the same, and method of producing a thioacetal compound
10/06/2005WO2005092845A1 Substituted heteroaryl- and phenylsulfamoyl compounds
10/06/2005US20050222426 A compound selected from the group consisting of 1,2,3-benzotriazol-2-yl-L-alanine, 5-carboxy-1,2,3-benzotriazol-2-yl-L-alanine, and 5-carboxy-1,2,3-benzotriazol-1-yl-L-alanine.
10/06/2005US20050222424 Phenyloxyalkanonic acid derivatives as hppar activators
10/06/2005US20050222423 Carboxylic acid derivative
10/06/2005US20050222254 Sulfonamide compounds for the treatment of neurodegenerative disorders
10/06/2005US20050222189 Oxa-and thiadiazoles and their use as metalloproteinase inhibitors
10/06/2005US20050222146 N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof
10/06/2005CA2559733A1 Inhibitors of histone deacetylase
10/06/2005CA2559035A1 Substituted heteroaryl- and phenylsulfamoyl compounds
10/05/2005EP1581509A2 1-(amino)indanes and (1,2-dihydro-3-amino)-benzofurans, benzothiophenes and indoles as edg receptor agonists
10/05/2005CN1678298A Use of an alpha2delta ligand such as gabapentin or pregabalin for treating ttention deficit hyperactivity disorder
10/04/2005US6951946 Reacting carboxy nitriles with hydroxylamine salts, then anhydriding the chemical intermediates and cyclization to form nitrogen compounds such as ethyl 5-(2-((t-butoxy)carbonyl amino)ethyl)-1,2,4-oxadiazole-3-carboxylate
10/04/2005US6951889 7-acetamidinyl derivatives
10/04/2005US6951878 Benzo[b]thiophenyl or tetrahydro-benzo[b]thiophenyl modulators of protein tyrosine phosphatases (PTPases)
09/2005
09/29/2005WO2005090298A1 Sulphonamide derivatives
09/29/2005WO2005090297A1 Sulphonamide derivatives
09/29/2005CA2559919A1 Sulphonamide derivatives
09/28/2005EP1578736A1 Mek inhibiting oxa- and thia-diazol-2-yl-phenylamine derivatives
09/28/2005EP1578735A1 Cyclopentyl glutaramides and their use as neutral endopeptidase inhibitors
09/28/2005CN1674892A Hetero biaryl derivatives as matrix metalloproteinase inhibitors
09/27/2005US6949551 Dihalopropene compounds, processes for their preparation, compositions comprising them and their use as pesticides
09/27/2005US6949534 An amide compound containing a very late antigen of activation-4 (VLA-4) specifity determinanat which doesn't impart significant IIb/IIIa activity; antiinflammatory agent and useful for treating autoimmune disorders
09/22/2005WO2005086871A2 Compounds, compositions and methods for inhibiting or treating hiv-1
09/22/2005WO2005068445A3 Pesticidal heterocyclic dihaloallyl compounds
09/22/2005US20050209286 RXR activating molecules
09/22/2005US20050209241 Benzoyl-piperazine derivatives
09/22/2005CA2559507A1 Compounds, compositions and methods for inhibiting or treating hiv-1
09/21/2005EP1575911A2 Biaromatic compounds which activate ppar-gamma type receptors, and use thereof in cosmetic or pharmaceutical compositions
09/21/2005EP1294679B1 Beta-amino acid nitrile derivatives
09/21/2005CN1671818A Metallic complexes covalently bound to conjugated polymers and electronic devices containing such compositions
09/15/2005US20050203150 Compounds, compositions and methods for inhibiting or treating HIV-1
09/14/2005EP1572629A1 COMPOUNDS WHICH MODULATE PPARϝ TYPE RECEPTORS, AND USE THEREOF IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS
09/14/2005CN1668593A Heterocyclically substituted benzoylureas, process for their preparation and their use as pharmaceuticals
09/14/2005CN1668291A Substituted phenylsulfonamide inhibitors of beta amyloid production
09/09/2005WO2005058884A3 Cyclopropane compounds and pharmaceutical use thereof
09/09/2005CA2554767A1 Method for preparing pyrrolidine oximes
09/07/2005EP1326853B1 Thiadiazoles and oxadiazoles and their use as phosphodiesterase-7 inhibitors
09/07/2005CN1665500A Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method
09/07/2005CN1217922C 2-amino-2-alkyl-4-hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors
09/06/2005US6939967 Non-proteinogenic L-amino acids
09/06/2005US6939880 Compounds with growth hormone releasing properties
09/06/2005US6939875 Carbocyclic oxy sulfides such as [4-(Biphenyl-4-ylmethylsulfanyl)-5-methoxy-2-methyl-phenoxy]-acetic acid, used to control peroxisome proliferator activated receptors (PPAR), for prophylaxis of metabolic disorders
09/01/2005WO2005080362A1 Cinnamic amides, process for their preparation, and pharmaceutical compositions containing them
09/01/2005US20050192289 Novel cinnamic amides
09/01/2005CA2552433A1 Cinnamic amides, process for their preparation, and pharmaceutical compositions containing them
08/2005
08/31/2005EP1567509A2 Biphenyl compounds which activate ppar-gamma type receptors, and use thereof in cosmetic or pharmaceutical compositions
08/31/2005EP1567498A2 Mandelic acid derivatives
08/31/2005CN1660815A Cyclic amine derivatives and their use as drugs
08/24/2005EP1565429A2 Aryl ureido derivatives and their medical use
08/24/2005EP1565422A1 Vitamin d receptor modulators
08/24/2005EP1334085B1 Sulfamides as gamma-secretase inhibitors
08/24/2005EP1144394B1 1-heterocycle substituted diarylamines
08/24/2005CN1658724A Luminescent element material and luminescent element comprising the same
08/23/2005US6933322 Substituted naphthylenes for the treatment of non-insulin dependent diabetes mellitus
08/18/2005WO2005075435A1 Modulators of atp-binding cassette transporters
08/18/2005WO2005074604A2 METHODS OF DETECTING Lp-PLA2 ACTIVITY
08/18/2005WO2005063742A3 Amidino compounds as cysteine protease inhibitors
08/18/2005CA2554796A1 Modulators of atp-binding cassette transporters
08/17/2005EP1562895A1 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
08/17/2005EP1280757B1 New gamma selective retinoids
08/17/2005EP1144385B1 Benzoheterocycles and their use as mek inhibitors
08/17/2005CN1656092A Robertson Graeme Michael et al.
08/16/2005US6930131 Hetero or aromatic-alkyloxyalkylphenylsulfonamide or analogs or derivatives useful in treating metabolic disorders mediated by insulin resistance or hyperglycemia
08/16/2005US6930111 Substituted heterocyclic compounds
08/11/2005WO2005072731A1 3-phenyl-n- ((1, 3, 4) thiadiazol-2-yl) -acrylamide derivatives and related compounds as modulators of estrogen-related receptors for the treatment of e.g. cancer, rheumatoid arthritis or neurological disorders
08/11/2005WO2005003081B1 Sulfonimide containing compounds and their use in polymer electrolyte membranes for electrochemical cells
08/11/2005US20050176765 For therapy of glaucoma, dementia such as Alzheimer's disease and vascular dementia, depression, attention deficit disorder, sleep disorder, schizophrenia, pain, ischemia; -[1-[1-(3-Thienoyl)piperidin-4-yl]piperidin-4-yl]-1,3-dihydro-2H-benzimidazol-2-one
08/10/2005EP1157002B1 1,2,3,4-tetrahydro-1-naphthalenamine compounds useful in therapy
08/10/2005CN1653073A Substituted phenylacetic acids
08/10/2005CN1652761A Preventive or therapeutic agent for kidney disease
08/10/2005CN1651420A Dehydro methyl abietate furazan derivative, its synthesis method and use
08/04/2005US20050171104 Novel thyroid receptor ligands
08/03/2005EP1558669A1 Electroluminescent metallo-supramolecules with terpyridine-based groups
08/03/2005EP1558591A2 Modulation of anxiety through blockade of anandamide hydrolysis
08/03/2005EP1558565A2 Halogenated selective androgen receptor modulators and methods of use thereof
08/03/2005CN1649829A Novel florfenicol-type antibiotics
08/03/2005CN1649820A Compounds that modulate PPAR activity and methods for their preparation
08/03/2005CN1649819A Novel thyroid receptor ligands
08/03/2005CN1213037C Halogenated pyrimidine and its application for reducing parasite
08/02/2005US6924300 Oxyiminoalkanoic acid derivatives
07/2005
07/28/2005WO2005068445A2 Pesticidal heterocyclic dihaloallyl compounds
07/28/2005WO2005068432A1 Malononitrile compound as pesticides
07/28/2005US20050165106 Preferentially inhibit the inducible isoform of nitric oxide synthase
07/28/2005US20050165019 Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same
07/28/2005US20050164973 E.g., 3-[5-(4-Fluoro-phenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid; treating diseases ameliorated by modulation of premature translation termination or nonsense-mediated mRNA decay
07/28/2005US20050164954 formula (I) has an inhibitory activity against cysteine protease and therefore it is useful as an agent for the prophylaxis and/or treatment of inflammatory diseases, diseases induced by apoptosis, diseases induced by disorders of immune responses, autoimmune diseases, diseases induced by decomposition
07/27/2005EP1047418B1 Inhibition of raf kinase using substituted heterocyclic ureas
07/27/2005CN1646505A Oxa- and thiadiazoles and their use as metalloproteinase inhibitors
07/26/2005CA2193388C Aryl and heteroaryl alkoxynaphthalene derivatives
07/26/2005CA2133439C Compounds useful for treating allergic and inflammatory diseases
07/21/2005WO2005066145A1 Heteroaryl-ureas and their use as glucokinase activators
1 ... 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 ... 72